Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Plos One|March 14, 2024
Role of two modules controlling the interaction between SKAP1 and SRC kinases comparison with SKAP2 architecture and consequences for evolutionLaurine Levillayer, Camille Brighelli, Caroline Demeret, et al.Frontiers in Immunology|March 14, 2022
SARS-CoV-2 Induces Cytokine Responses in Human BasophilsSrinivasa Reddy Bonam, Camille Chauvin, Laurine Levillayer, et al.Plos Neglected Tropical Diseases|October 17, 2024
Zika virus T-cell based 704/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodiesClaude Roth, Bruno Pitard, Laurine Levillayer, et al.PLOS Global Public Health|January 12, 2026
First detection of one of the tick-borne lymphadenopathy (TIBOLA) etiological agent in ticks from a highly frequented sub-urban forest near Paris, FranceEva A Krupa, Laurine Levillayer, Matthieu Prot, et al.Molecular & Cellular Proteomics : MCP|November 24, 2022
SKAP2 Modular Organization Differently Recognizes SRC Kinases Depending on Their Activation Status and LocalizationLaurine Levillayer, Patricia Cassonnet, Marion Declercq, et al.Frontiers in Immunology|July 12, 2019
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic MiceClaude Roth, Tineke Cantaert, Chloé Colas, et al.International Journal of Antimicrobial Agents|January 2, 2021
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazineMarion Plaze, David Attali, Matthieu Prot, et al.Nature Communications|November 2, 2021
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamstersPhanramphoei N Frantz, Aleksandr Barinov, Claude Ruffié, et al.Iscience|February 13, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsCamille Chauvin, Laurine Levillayer, Mathilde Roumier, et al.Pageof 1